Even though the number of patients and controls was insufficient to establish statistical significance at the protein level, we observed higher levels of DGKA in several AML samples compared to CD34+ or lin− controls, whereas no such difference was seen for DGKZ (Supplementary Figure S2). This evidence concerns the gene DGKZ and acute myeloid leukemia.